Myeloid Leukemia, Philadelphia-Positive

Myeloid Leukemia, Philadelphia-Positive — Trials · CancerIndex

Clinical trials

Registered studies

17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7
Recruiting: 3
Ph III recruiting: 1
Growth YoY: —
Industry share: 43%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04925479	Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia	recruiting	Phase 1 / Phase 2	34	Novartis PharmaceuticalsINDUSTRY	14	Sep 25, 2026	clinicaltrials
NCT04258943	Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia	active not recruiting	Phase 1 / Phase 2	60	Children's Oncology GroupNETWORK	8	Sep 18, 2025	clinicaltrials